Cel Sci Corporation (CVM)

[lightrock]

@GD

From what I understand on NWBO, a subset of their enrolled population responded well, the kind of well that if you are well funded you halt and re-launch with a specific targeted enrollment, but they couldn't or didn't.

Seems like "it works"... for particular people, but the trial was not knowing of this up-front enough to dial a more dramatic results by way of enrolling just the effective ones up-front when it started.

Will that evidence-so-far be enough for them to get to FDA with it...

We could be in that same situation and not know it here, yet. But I'm pretty sure we have a bigger over all "signal" of effectiveness.

In their case, NWBO, they could actually get a buyout even if this particular trial set-up failed, because their IP might be worth a lot if run again, the right way.